David Sirois | Director of Corporate Accounting & SEC Reporting |
James Green | President & Chief Executive Officer |
Michael Rossi | Chief Financial Officer |
Paul Knight | KeyBanc Capital Markets |
Tim Chiang | Northland Capital Markets |
Bruce Jackson | The Benchmark Company |
Good morning, ladies and gentlemen. Thank you for standing by and welcome to the Harvard Bioscience, Inc.
First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session.